NCT05898620Phase 3Active not recruiting

A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett Syndrome

Study sponsor: Neurogene Inc. · NGNE

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2029-12Estimated
Enrollment · participants33Estimated
Source updated2026-06-10Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview